Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Weight Loss/Management

Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial

L. E. Burke; M. A. Styn; S. M. Sereika; M. B. Conroy; L. Ye; K. Glanz; M. A. Sevick; L. J. Ewing Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial Am J Prev Med

Mobile Health Applications in Weight Management: A Systematic Literature Review

K. Dounavi; O. Tsoumani Mobile Health Applications in Weight Management: A Systematic Literature Review Am J Prev Med

Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study

P. Behary; G. Tharakan; K. Alexiadou; N. Johnson; N. J. Wewer Albrechtsen; J. Kenkre; J. Cuenco; D. Hope; O. Anyiam; S. Choudhury; H. Alessimii; A. Poddar; J. Minnion; C. Doyle; G. Frost; C. Le Roux; S. Purkayastha; K. Moorthy; W. Dhillo; J. J. Holst; A. Combined GLP-1, Oxyntomodulin, and Peptide YY Improves Body Weight and Glycemia in Obesity and Prediabetes/Type 2 Diabetes: A Randomized, Single-Blinded, Placebo-Controlled Study Diabetes Care
Insulin Resistance & Diabetes

Exposure-response analyses of liraglutide 3.0 mg for weight management

J. P. Wilding; R. V. Overgaard; L. V. Jacobsen; C. B. Jensen; C. W. le Roux Exposure-response analyses of liraglutide 3.0 mg for weight management Diabetes Obes Metab

Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis

P. M. Ryan; S. Seltzer; N. E. Hayward; D. A. Rodriguez; R. T. Sless; C. P. Hawkes Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis J Pediatr

Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients

M. Suliman; A. Buckley; A. Al Tikriti; T. Tan; C. W. le Roux; N. Lessan; M. Barakat Routine clinical use of liraglutide 3 mg for the treatment of obesity: Outcomes in non-surgical and bariatric surgery patients Diabetes Obes Metab

Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial

J. S. Tronieri; T. A. Wadden; O. A. Walsh; R. I. Berkowitz; N. Alamuddin; K. Gruber; S. Leonard; A. M. Chao Effects of liraglutide plus phentermine in adults with obesity following 1 year of treatment by liraglutide alone: A randomized placebo-controlled pilot trial Metabolism

Prescribing for weight loss in primary care: evidence from a population based study

L. Patterson; C. Patterson; F. Kee; C. Hughes; M. Donnelly; D. O'Reilly Prescribing for weight loss in primary care: evidence from a population based study J Epidemiol Community Health

A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management

X. Pi-Sunyer; A. Astrup; K. Fujioka; F. Greenway; A. Halpern; M. Krempf; D. C. Lau; C. W. le Roux; R. Violante Ortiz; C. B. Jensen; J. P. Wilding A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management N Engl J Med

Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes

V. Pathak; P. R. Flatt; N. Irwin Cholecystokinin (CCK) and related adjunct peptide therapies for the treatment of obesity and type 2 diabetes Peptides
Insulin Resistance & Diabetes

Older posts

Newer posts

← Previous Page1 … Page14 Page15 Page16 … Page25 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2026 ASOI